Harvard Molecular Diagnostics: Current Roles in Cancer Diagnosis 2026

The Harvard Molecular Diagnostics: Current Roles in Cancer Diagnosis 2026 program delivers an advanced and clinically focused review of modern molecular oncology and precision cancer diagnostics. Designed for pathologists, oncologists, and laboratory leaders, this comprehensive course explores how emerging molecular technologies are transforming cancer classification, biomarker discovery, targeted therapy selection, and personalized patient care.

As molecular pathology becomes increasingly central to oncology practice, clinicians and laboratory professionals must understand not only the biology behind genomic alterations, but also the practical application of molecular testing platforms, bioinformatics pipelines, liquid biopsy technologies, and integrated diagnostic workflows. This course provides a detailed overview of current molecular diagnostic strategies used across solid tumors, hematologic malignancies, and hereditary cancer syndromes.

Through expert-led lectures, case-based discussions, and tumor-focused molecular reviews, participants gain practical insight into:

• Next-generation sequencing (NGS)
• RNA- and DNA-based testing
• Gene fusion interpretation
• Liquid biopsy and circulating tumor DNA (ctDNA)
• Tumor mutational burden (TMB)
• Microsatellite instability (MSI)
• Homologous recombination deficiency (HRD)
• AI applications in molecular oncology
• Cytogenomics and methylation profiling

The curriculum combines technical molecular laboratory knowledge with clinically relevant oncology applications, helping healthcare professionals integrate advanced molecular diagnostics into modern precision medicine practice.

---

Course Details

• Format: 40 Videos (.mp4) + 40 Subtitle Files (.vtt) + 41 PDFs
• Total Size: 5.47 GB
• Course Dates: April 13–15, 2026
• Institution: Harvard Medical School
• Access: On-demand
• Focus: Molecular Oncology & Cancer Diagnostics

---

What You Will Learn

Participants will develop a stronger understanding of contemporary molecular cancer diagnostics and precision oncology workflows, including:

• Principles and methodologies of molecular oncology testing
• Interpretation of molecular biomarkers for diagnosis and therapy selection
• Practical applications of next-generation sequencing (NGS)
• RNA- and DNA-based gene fusion analysis
• Bioinformatics pipelines and molecular data interpretation
• Liquid biopsy and circulating tumor DNA applications
• Molecular classification of solid tumors and hematologic malignancies
• Tumor mutational burden (TMB), MSI, and HRD analysis
• Methylation profiling and cytogenomic techniques
• Integration of molecular findings into multidisciplinary cancer care
• Regulatory, reimbursement, and laboratory implementation considerations
• Communication of molecular test results to clinicians and patients

The course also emphasizes real-world clinical integration, helping participants understand how molecular diagnostics directly influence treatment decisions, prognostic assessment, and precision oncology strategies.

---

Core Topics Covered

Next-Generation Sequencing (NGS) & Molecular Pipelines

A major focus of the course is advanced NGS technologies and laboratory workflows.

Topics include:

• NGS pipeline architecture
• Bioinformatics interpretation
• Variant calling
• Indel detection
• RNA- and DNA-based sequencing
• Long-read sequencing technologies
• Molecular informatics infrastructure

Participants gain practical understanding of how modern sequencing platforms are implemented and interpreted in clinical oncology laboratories.

---

Gene Fusion Detection & RNA-Based Diagnostics

The course provides extensive education on:

• Gene fusion testing
• RNA-based NGS analysis
• Oncogenicity interpretation
• Isoform and sub-gene event detection
• Fusion-driven malignancies

Case-based sessions review clinically relevant gene fusion interpretation across multiple tumor types, including sarcomas, gliomas, and lung cancers.

---

Liquid Biopsy & Circulating Tumor DNA (ctDNA)

Advanced liquid biopsy sessions explore:

• ctDNA technologies
• Clinical applications of liquid biopsy
• Tissue vs liquid biopsy decision-making
• Monitoring treatment response
• Molecular residual disease detection

The course reviews both technical considerations and clinical implementation of minimally invasive molecular cancer testing.

---

Tumor Biomarkers & Precision Oncology

Participants review important molecular biomarkers used in modern oncology practice, including:

• Tumor mutation burden (TMB)
• Microsatellite instability (MSI)
• Homologous recombination deficiency (HRD)
• Copy number variation (CNV)
• Viral sequence detection
• Pharmacogenomics in oncology

These modules focus on the role of molecular markers in:

• targeted therapy selection,
• immunotherapy guidance,
• prognostic stratification,
• and precision medicine decision-making.

---

Molecular Diagnostics by Tumor Type

The program includes tumor-specific molecular pathology updates covering:

• Lung cancer
• Breast cancer
• Gynecologic tumors
• Pediatric tumors
• Thyroid and salivary tumors
• Gliomas
• Melanoma
• Sarcomas
• Gastrointestinal cancers
• Genitourinary cancers
• Leukemia and lymphoma
• Myeloid neoplasms

Each section integrates molecular testing strategies with clinical oncology management and evolving therapeutic targets.

---

Cytogenomics & Methylation Profiling

Advanced laboratory diagnostics sessions include:

• Cytogenomic analysis
• Chromosomal abnormality detection
• Copy number variation testing
• Methylation profiling in gliomas
• Microarray technologies

Participants gain insight into the expanding role of epigenetics and chromosomal analysis in modern cancer diagnostics.

---

Germline Testing & Tumor-Normal Sequencing

The course reviews:

• Hereditary cancer testing
• Germline mutation analysis
• Tumor-normal paired sequencing
• Clinical interpretation of inherited variants
• Ethical and clinical considerations in oncology genetics

These sessions emphasize precision medicine approaches that integrate both somatic and inherited genomic information.

---

AI & Future Directions in Molecular Oncology

Emerging technologies and future trends are also explored, including:

• Artificial intelligence in molecular pathology
• Computational oncology
• Predictive analytics
• Workflow automation
• Future diagnostic platforms

Participants gain perspective on how AI and advanced informatics may reshape molecular cancer diagnostics in coming years.

---

Educational Features

Expert Harvard Faculty

The course is taught by experienced molecular pathologists, oncologists, laboratory directors, and bioinformatics specialists with expertise in:

• molecular oncology,
• cancer genomics,
• precision medicine,
• cytogenetics,
• and translational diagnostics.

---

Case-Based Learning

Several sessions incorporate:

• multidisciplinary case reviews,
• tumor board simulations,
• pathology-oncology discussions,
• and practical molecular interpretation exercises.

This approach strengthens real-world clinical application and diagnostic reasoning.

---

Practical Laboratory Focus

The program addresses not only molecular biology concepts, but also:

• laboratory implementation,
• workflow optimization,
• reimbursement,
• reporting standards,
• and regulatory considerations.

This makes the course particularly useful for laboratory leadership and molecular diagnostics program development.

---

Multimedia Learning Resources

The course includes:

• High-quality video lectures
• Downloadable PDF materials
• Subtitle files (.vtt)
• Interactive workshops
• Case-based presentations

The on-demand format supports flexible review and repeated study.

---

Target Audience

This course is ideal for:

• Pathologists
• Molecular pathologists
• Oncologists
• Hematopathologists
• Laboratory directors
• Clinical laboratory professionals
• Translational researchers
• Precision medicine specialists
• Fellows and trainees in pathology or oncology

It is especially valuable for professionals seeking updated expertise in:

• NGS,
• molecular tumor profiling,
• liquid biopsy,
• molecular pathology,
• and precision oncology diagnostics.

---

Why This Course Matters

Molecular diagnostics now plays a central role in nearly every aspect of modern oncology, from diagnosis and prognostic assessment to targeted therapy selection and disease monitoring. As genomic technologies rapidly evolve, clinicians and laboratory professionals must stay current with new testing platforms, biomarker interpretation strategies, and precision medicine workflows.

This Harvard program provides a clinically relevant and technically detailed review of contemporary molecular oncology, helping participants bridge the gap between advanced laboratory science and practical cancer care.

Its combination of molecular pathology, bioinformatics, liquid biopsy, tumor-specific diagnostics, and laboratory implementation makes it highly valuable for healthcare professionals working in precision oncology and cancer diagnostics.

TOPICS

1. 01 Integrated Molecular Oncology in 2026 Trends and Tools for Gene Fusion Detection

2. 02 End-to-end Process to Accelerating Treatment Initiation with Next-day NGS

3. 03 Translation of Molecular to Immunohistochemistry

4. 04 Informatics Architecture

5. 05 NGS Pipelines Demystified Practical Bioinformatics

6. 06 Tumor Mutation Burden, MSI, and HRD

7. 07 Indel Detection

8. 08 Viral Sequence Detection and Other Signatures

9. 09 Gene Fusion Detection and Interpretation by RNA-based NGS a Practical, Cased-based Approach

10. 10 Additional Informatics Analyses Detection of Clinically Significant Isoforms and Sub-gene Events through RNA andor DNA-based NGS

11. 11 Oncogenicity Interpretation of Gene Fusions Detected by RNA-based NGS

12. 12 Applications of Long-Read Sequencing for Cancer Diagnostics

13. 13 Liquid Biopsy and ctDNA Technical and Clinical Perspectives

14. 14 Panel Discussion Tissue vs Liquid Biopsy

15. 15 Sarcoma and Fusion Testing

16. 16 Molecular Diagnostics for GYN Tumors

17. 17 Molecular Diagnostics for Pediatric Tumors

18. 18 GU Cancers Molecular Markers (Only PDF, No Video)

19. 19 Copy Number Variation via NGS and Microarray

20. 20 Cytogenomics Technical Focus

21. 21 Cytogenomics Clinical Focus

22. 22 Gliomas and Methylation Profiling

23. 23 Germline Testing in Oncology What, When, and How

24. 24 Tumor-Normal Paired Sequencing Clinical Impact

25. 25 Case Review Pathology Oncology Perspectives

26. 26 Melanoma Molecular Pathology

27. 27 Molecular Diagnostics for Breast Cancer

28. 28 Tumor Board Simulation Real Case Review

29. 29 Myeloid Neoplasms and MRD Testing

30. 30 Leukemia Molecular Diagnostics (B- and T-cell)

31. 31 Molecular Diagnostics and Lymphoma

32. 32 Pharmacogenomics in Oncology Management

33. 33 Lung Tumor Testing

    34. GI Cancer Case-Based Applications VIDEO + PDF Not Release

34. 35 Thyroid Cancer and Salivary Tumor Genomics

35. 36 AI in Molecular Oncology

36. 37 Interactive Workshop Case Report Writing and Communication

37. 38 The Power of Patient Partnership in Cancer Advocacy

38. 39 Building a Molecular Profiling Program

39. 40 Regulatory and Reimbursement Essentials

40. 41 Lab Leadership and Challenges

41. 42 Future Directions in Molecular Oncology